New York State Common Retirement Fund’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-53,211
Closed -$7.45M 3199
2018
Q4
$7.45M Buy
53,211
+21,161
+66% +$3.21M 0.01% 1013
2018
Q3
$5.47M Buy
32,050
+600
+2% +$101K 0.01% 1231
2018
Q2
$5.46M Buy
31,450
+6,750
+27% +$1.01M 0.01% 1236
2018
Q1
$2.85M Buy
24,700
+400
+2% +$42.5K ﹤0.01% 1454
2017
Q4
$2.05M Sell
24,300
-797
-3% -$66.4K ﹤0.01% 1629
2017
Q3
$2.31M Buy
25,097
+700
+3% +$54.4K ﹤0.01% 1559
2017
Q2
$1.96M Buy
24,397
+8,696
+55% +$482K ﹤0.01% 1685
2017
Q1
$661K Buy
15,701
+1,001
+7% +$41.2K ﹤0.01% 2242
2016
Q4
$472K Sell
14,700
-4,173
-22% -$107K ﹤0.01% 2396
2016
Q3
$494K Buy
18,873
+4,400
+30% +$115K ﹤0.01% 2320
2016
Q2
$335K Buy
14,473
+523
+4% +$13K ﹤0.01% 2470
2016
Q1
$381K Buy
13,950
+3,200
+30% +$67K ﹤0.01% 2362
2015
Q4
$306K Hold
10,750
﹤0.01% 2550
2015
Q3
$188K Sell
10,750
-766
-7% -$15K ﹤0.01% 2817
2015
Q2
$208K Buy
11,516
+6,416
+126% +$87.7K ﹤0.01% 2902
2015
Q1
$63K Buy
+5,100
New +$63.5K ﹤0.01% 2248

Other funds holding LOXO

New York State Common Retirement Fund's LOXO Position: Q1 2019 in Review

New York State Common Retirement Fund sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 53,211 shares — an estimated $7.45M sold.

New York State Common Retirement Fund first reported a position in LOXO in Q1 2015 and held it in 16 quarters. The position peaked at $7.45M in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • New York State Common Retirement Fund reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • New York State Common Retirement Fund sold 53,211 Loxo Oncology, Inc shares in Q1 2019, an estimated $7.45M.
  • New York State Common Retirement Fund first reported a position in Loxo Oncology, Inc in Q1 2015 and held it in 16 quarters.
  • New York State Common Retirement Fund's Loxo Oncology, Inc position peaked at $7.45M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on New York State Common Retirement Fund's 13F filing for Q1 2019, filed 8 May 2019.